PharVision Advisers’s TripAdvisor TRIP Stock Holding History

PharVision Advisers’s Portfolio TRIP Stock Details TRIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-15,059	Closed	-$245K	–	1004
2025 Q3	$245K	Buy	+15,059	New	+$263K	0.14%	347

Other funds holding TRIP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Starboard Value New York $4.52B AUM 19.34% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

SAM

Southeastern Asset Management Memphis, Tennessee $1.92B AUM 6.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PharVision Advisers's TRIP Position: Q4 2025 in Review

PharVision Advisers sold out of TripAdvisor (TRIP) in Q4 2025, closing a stake of 15,059 shares — an estimated $245K sold.

PharVision Advisers first reported a position in TRIP in Q3 2025 and held it in 1 quarter. The position peaked at $245K in Q3 2025. 315 funds tracked by Wall St. Rank hold TRIP as of Q4 2025.

PharVision Advisers reported no remaining TripAdvisor position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 15,059 TripAdvisor shares in Q4 2025, an estimated $245K.
PharVision Advisers first reported a position in TripAdvisor in Q3 2025 and held it in 1 quarter.
PharVision Advisers's TripAdvisor position peaked at $245K in Q3 2025.
315 funds tracked by Wall St. Rank held TripAdvisor as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.